This guide checks the Ministry of Food and Drug Safety announcement of 2 November 2026 and its attached official PDF. In Korea, consulting a health professional, reporting a suspected adverse drug reaction, and enquiring about injury relief serve different purposes. This article cannot assess anyone's symptoms or direct them to stop or continue a particular medicine. For severe or urgent symptoms, including breathing difficulty or a change in consciousness, seek emergency medical care immediately; Korea's emergency number is 119. The cover is AI-generated concept art, not a photograph of an actual medicine, agency or campaign.
First, discuss the suspected reaction with a professional
The ministry advises people who suspect a side effect after using a medicine to consult a medical professional. You do not need to establish a causal link on your own before asking for advice. It can help to note the product name or ingredient, when and how it was taken, when the symptoms began and how they developed, and any other medicines or products taken at the same time. Explain your actual situation to a doctor or pharmacist. Whether a dose or treatment should change is an individual clinical decision, not one this general guide can make.
Reporting a suspected reaction
The announcement identifies 1644-6223 as a telephone route for reporting suspected adverse drug reactions. It also names Drug Safety Korea (의약품안전나라) and a nearby regional pharmacovigilance centre. These centres collect reports and provide consultations and causality assessments. A report is a way to share a suspected event for safety monitoring; it is not, by itself, a medical diagnosis or proof that the medicine caused the symptoms. Find the current centre list and online reporting interface through the official service rather than assuming a particular screen path will remain unchanged.
If you are preparing a report, record the medicine name, timing of use, the first sign of the symptoms, subsequent changes, other products used and any medical consultation if known. Packaging or a prescription can be useful, but a complete file is not a prerequisite for seeking medical advice. Use the official reporting channel for personal health information rather than posting it publicly. Follow the receiving body's instructions for any additional details.
Injury-relief enquiries are a separate route
For questions about applying to Korea's adverse drug reaction injury-relief program, the release gives the Korea Institute of Drug Safety & Risk Management consultation number 14-3330. The ministry describes the program as state compensation for unexpected serious harm—death, disability or illness—despite appropriate medicine use. Reporting a suspected event on 1644-6223 does not automatically submit an injury-relief application or guarantee compensation. Ask the program's consultation service about eligibility, documentation, review and outcome; do not infer approval from a report or a phone enquiry. Nor should considering a relief claim delay medical attention for current symptoms.
The campaign dates are not a reporting deadline
The 2026 Medicine Safety Campaign runs from 2 to 18 November, with 28 regional centres involved in education and outreach about safe medicine use, reporting and the relief scheme. The release does not describe 18 November as the final day for individuals to report suspected reactions. If you need a reporting route later, check the latest contact details, hours and centre list at Drug Safety Korea or the safety institute. The existence of a campaign does not freeze every service interface or telephone arrangement indefinitely. We did not reproduce the official campaign poster or illustrations without checking their rights.
Keep the three decisions distinct
If the situation is urgent, seek emergency care first. For a suspected medicine reaction, consult a medical professional. To share a suspected case with the safety system, use the current reporting route—1644-6223, Drug Safety Korea or a regional centre. For a separate question about possible relief after serious harm, contact 14-3330. These are practical routes to obtain help and information; none is a diagnosis, an automatic compensation decision or a substitute for the others. The Korean Naver article presents a shorter question-led checklist.
About the Author
The Life Mokcha editorial team reviews official announcements and primary sources to explain practical information. Check the linked original sources for applicable terms and later updates.
